Cannassure Therapeutics Ltd Stock

Equities

CSURE-M

IL0001110134

Healthcare Facilities & Services

Market Closed - TEL AVIV STOCK EXCHANGE 10:24:27 2024-06-05 am EDT 5-day change 1st Jan Change
1,800 ILa 0.00% Intraday chart for Cannassure Therapeutics Ltd -5.26% +272.67%
Sales 2022 33.78 12.54K Sales 2023 11 4.08K Capitalization 4M 1.49B
Net income 2022 -5M -1.86B Net income 2023 -1M -371M EV / Sales 2022 1,023,292 x
Net Debt 2022 29.96M 11.13B Net Debt 2023 2.43M 904M EV / Sales 2023 585,038 x
P/E ratio 2022
-0.84 x
P/E ratio 2023
-2.24 x
Employees 2
Yield 2022 *
-
Yield 2023
-
Free-Float 85.34%
More Fundamentals * Assessed data
Dynamic Chart
1 week-5.26%
Current month+5.20%
1 month+26.40%
3 months+179.94%
6 months+197.03%
Current year+272.67%
More quotes
1 week
1 680.00
Extreme 1680
1 800.00
1 month
1 500.00
Extreme 1500
2 075.00
Current year
430.00
Extreme 430
2 075.00
1 year
291.00
Extreme 291
2 075.00
3 years
291.00
Extreme 291
8 580.00
5 years
291.00
Extreme 291
16 700.00
10 years
291.00
Extreme 291
34 500.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 54 22-03-30
Chairman 51 18-12-03
Comptroller/Controller/Auditor 69 19-06-25
Members of the board TitleAgeSince
Director/Board Member 71 18-12-03
Chairman 51 18-12-03
Director/Board Member 56 22-02-13
More insiders
Date Price Change Volume
24-06-05 1,800 0.00% 650
24-06-04 1,800 +6.07% 152
24-06-02 1,697 -0.82% 1,748
24-05-30 1,711 -9.95% 358
24-05-29 1,900 -0.26% 1,734

Delayed Quote TEL AVIV STOCK EXCHANGE, June 05, 2024 at 10:24 am EDT

More quotes
Cannassure Therapeutics Ltd, formerly Direct Capital Investments Ltd, is an Israel-based real estate company. The Company has two main business activities; Yielding real estate and real estate investments in which the Company, directly and through its subsidiaries; locates, purchases, rents, upgrades and manages real estate. The Company and its subsidiaries have investments and property rights in Germany, Serbia, India, Kazakhstan, Latvia and Israel.
More about the company
  1. Stock Market
  2. Equities
  3. CSURE-M Stock